洞察ZIF-8对药物和蛋白质/细胞之间的相互作用的影响
Ying Zheng1, Xin-Yue Duan2, Xin Wang3
1Artemisinin Research Center, China Academy of Chinese Medical Sciences, Beijing 100700, China.
International journal of biological macromolecules
|January 6, 2025
概括
氧化伊米达酸框架-8 (ZIF-8) 影响药物蛋白相互作用,增强黄素和西普罗夫洛克萨的疗效. 这种纳米材料影响药物细胞相互作用,影响生物结果.
科学领域:
- 纳米医学是一种纳米医学.
- 生物化学 生物化学
- 材料科学 材料科学 材料科学
背景情况:
- 了解纳米材料与生物系统的相互作用是它们应用的关键.
- 药物-蛋白质和药物-细胞相互作用显著影响治疗疗效.
- 氧化伊米达酸框架-8 (ZIF-8) 是一种具有潜在生物医学应用的纳米材料.
研究的目的:
- 研究ZIF-8对黄素 (Cur) 和人血清白蛋白 (HSA) 之间的相互作用的影响.
- 使用HepG2细胞和大肠杆菌 (大肠杆菌) 检查ZIF-8对药物细胞相互作用的影响.
- 评估ZIF-8如何影响药物蛋白质复合物的生物疗效.
主要方法:
- 使用光谱技术 (紫外线,光) 来研究Cur-HSA-ZIF-8相互作用.
- 进行了分子对接模拟,以阐明结合机制.
- 进行了基于细胞的测定,以评估药物细胞相互作用和生物活性.
主要成果:
- ZIF-8与Cur-HSA复合体相互作用,形成基态复合体,而不会改变主要的结合机制或固态度.
- ZIF-8在HSA的二次结构和酶活性中引起了微妙的变化.
- ZIF-8增强了Cur-HSA的抗瘤活性和西普洛素 (CIP) -HSA的抗菌疗效,改善了大肠杆菌对CIP的吸收.
结论:
- ZIF-8调节药物-蛋白相互作用,导致药物疗效的显著改变.
- 纳米材料对药物蛋白结合的影响影响治疗活性和细胞吸收.
- ZIF-8显示了提高现有药物配方性能的潜力.
相关概念视频
Factors Affecting Protein-Drug Binding: Drug Interactions
100
Drug interactions are a critical aspect of pharmacology and can occur when two or more drugs compete for the same binding site. This competition can result in one drug displacing another, altering the effect of the displaced drug. Drug interactions are complex processes that rely heavily on how much of the displacer drug is present and how strongly it can bind to the same sites as the displaced drug.
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
100
Factors Affecting Protein-Drug Binding: Protein-Related Factors
118
Drug binding to proteins is a key aspect of pharmacokinetics and can influence a drug's distribution, absorption, and elimination in the body. Several factors, including the drug's physiochemical properties, protein concentration, disease states, and the number of binding sites on the protein, influence this process.
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
118
Protein-Drug Binding: Mechanism and Kinetics
278
Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
278
Protein-protein Interfaces
12.4K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.4K
Factors Affecting Protein-Drug Binding: Drug-Related Factors
78
Drug binding to proteins is a complex phenomenon influenced by various drug-related factors, each playing a significant role in the interaction between drugs and proteins within the body.
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
78
Drug-Receptor Bonds
2.7K
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
In...
2.7K


